Company recognized from more than 100 companies for innovative technology
SALT LAKE CITY, May 4 /PRNewswire/ -- Axial Biotech, Inc., a company revolutionizing spine care through the development of molecular diagnostic technologies, was selected as the winner at the 9th Annual Utah Innovation Award Ceremony. The award recognizes significant innovations and the companies that created them. The Utah Technology Council and Stoel Rives, LLP presented the award to Axial Biotech during an awards ceremony held Thursday, April 30, 2009.
Axial Biotech's award winning product, ScoliScore(TM), is the first-ever genetic test for patients diagnosed with Adolescent Idiopathic Scoliosis (AIS). This new molecular diagnostic tool marks a major advancement in which medical treatments can be personalized to patients diagnosed with this deforming disease.
ScoliScore(TM) was developed by utilizing a genome wide association study that identified a panel of genetic markers associated with severe curve progression. The scoliosis research used in the development of this test included collecting DNA samples from over 9,500 patients from 85 clinical sites throughout the world. The test was then further validated in two separate clinical trials.
"We are honored to have won the Biotechnology/Pharmaceutical category given that the other finalists were Nanopartz and GlycoMira, LLC, which are both remarkable companies that have developed impressive technologies," said Kenneth Ward, M.D., Chairmen of the Board and Chief Medical Officer. "Past winners in the Biotechnology category include the 2004 winner, ARUP Laboratories, a leading national diagnostic reference laboratory. To have Axial Biotech viewed in this same league represents an important accomplishment for our company."
John Climaco, CEO and President of Axial Biotech, said, "I am pleased that the distinguished panel of experts from private industry,
|SOURCE Axial Biotech, Inc.|
Copyright©2009 PR Newswire.
All rights reserved